Poster 32: GASTRIC INVOLVEMENT – A RARE AND CHALLENGING SITE OF
EXTRAMEDULLARY MYELOMA
Joana Monteiro, Daniela Coelho, José Pedro Carda and Marília Gomes
Poster 33: A DESCRIPTIVE COST-ANALYSIS OF MYX.1/MCRN003, A PHASE 2 CLINICAL
TRIAL EVALUATING HIGH-DOSE WEEKLY CARFILZOMIB,
CYCLOPHOSPHAMIDE, AND DEXAMETHASONE IN RELAPSED AND
REFRACTORY MULTIPLE MYELOMA
Bethany E. Monteith, Christopher P. Venner, Matthew C. Cheung, Joe L. Pater, Lois
Shepherd, Harriet Richardson, Donna Reece, Engin Gul, Marc Lalancette, Vincent
Castonguay, Vishal Kukreti, Rodger Tiedemann, Chai Phua, Sita Bhella, Jill Dudebout,
Max Sherry, Hope Yen, Bingshu E. Chen and Annette E. Hay
Poster 34: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND
DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE
MYELOMA (RRMM) REFRACTORY TO AN IMID AND/OR A PROTEASOME
INHIBITOR (PI) — UPDATED EFFICACY AND SAFETY
Enrique M. Ocio, Yvonne A. Efebera, Roman Hájek, Miquel Granell, Vladimir Maisnar,
Jan Straub, Jean-Richard Eveillard, Lionel Karlin, Vincent Ribrag, María-Victoria Mateos,
Albert Oriol, Malin Sydvander, Stefan Norin, Sofia Männikkö and Luděk Pour
Poster 35: UPDATED ANALYSIS OF DARATUMUMAB PLUS LENALIDOMIDE AND
DEXAMETHASONE (D-RD) VERSUS LENALIDOMIDE AND DEXAMETHASONE
(RD) IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED
MULTIPLE MYELOMA (NDMM): THE PHASE 3 MAIA STUDY
Aurore Perrot, Thierry Facon, Saad Z. Usmani, Torben Plesner, Robert Z. Orlowski, Cyrille
Touzeau, Supratik Basu, Nizar J. Bahlis, Hartmut Goldschmidt, Michael O'Dwyer,
Christopher P. Venner, Katja Weisel, Cyrille Hulin, Lionel Karlin, Meir Preis, Annemiek
Broyl, William Renwick, Markus Hansson, Maria Krevvata, Jianping Wang, Rian Van
Rampelbergh, Jon Ukropec, Clarissa M. Uhla9, Rachel Kobos and Shaji Kumar
Poster 36: PLASMACYTOMA INVOLVING THE UPPER AIRWAY – CASE SERIES FROM A
TERTIARY CARE CENTER
Arun Prasath N, Dr. Geetha N, Dr. Sugeeth MT and Dr.Lali VS
Poster 37: A CASE REPORT OF RECURRENT EXTRAMEDULLARY MULTIPLE MYELOMA
AND CYTOPENIA IMPACTING TREATMENT
Shane Reeves and Gregory Monohan
Poster 38: LONG-TERM OUTCOMES AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) BY
RESPONSE STATUS FOR BORTEZOMIB, MELPHALAN, AND PREDNISONE (VMP)
± DARATUMUMAB IN ALCYONE
Paula Rodriguez-Otero, Mario Boccadoro, Roman Hajek, Tomoaki Fujisaki, Jae Hoon Lee,
Joaquin Martinez-Lopez, Paulo Lucio, Zsolt Nagy, Ganna Usenko, Anna Marina Liberati,
Mihaela Cornelia Lazaroiu, Dariusz Woszczyk, Hiroyuki Takamatsu, Joanna Romejko-
Jarosinska, Stefan Knop, Astrid Pavlovsky, Cecily Forsyth, Takayuki Ishikawa, Katharine
S. Gries, Huiling Pei, Anupa Kudva, Jon Ukropec, Susan Wroblewski, Robin Carson and
Meletios A. Dimopoulos